Trials / Completed
CompletedNCT01802411
Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 191 (actual)
- Sponsor
- Pacira Pharmaceuticals, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to examine the safety and efficacy of liposome bupivacaine for intercostal nerve block in subjects undergoing posterolateral thoracotomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EXPAREL 266 mg | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2013-03-01
- Last updated
- 2021-07-12
- Results posted
- 2020-12-09
Locations
21 sites across 5 countries: United States, Bulgaria, Czechia, Georgia, Poland
Source: ClinicalTrials.gov record NCT01802411. Inclusion in this directory is not an endorsement.